At a glance
- Originator Academy of Sciences of the Czech Republic; Rega Institute for Medical Research
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action DNA inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Adenovirus infections